25 research outputs found
Eurotransplant and the role of Croatia in Eurotransplant
Eurotransplant je meÄunarodna neprofitna organizacija koja se bavi alokacijom i prekograniÄnom razmjenom kadaveriÄnih organa za transplantaciju. Osnovana je 1967. godine i okuplja osam zemalja Älanica s preko 135 milijuna stanovnika, a Republika Hrvatska je Älanica od 2007. godine. Älanstvo u Eurotransplantu za Hrvatsku je korisno zbog omoguÄavanja Å”to bolje podudarnosti darivatelja i primatelja, kao i moguÄnosti da se u kratkom vremenu pronaÄe organ u sluÄajevima akutnog zatajenja organa, za Å”to je bitno veÄa vjerojatnost u velikoj populaciji potencijalnih darivatelja organa. Tijekom posljednjih deset do petnaest godina u Hrvatskoj je doÅ”lo do velikog porasta broja kadaveriÄnih darivatelja organa i broja transplantacija te ona danas zauzima jedno od vodeÄih mjesta u svijetu po broju darivatelja i transplantacija na milijun stanovnika, a jedan od Äimbenika koji su za to zaslužni je i Älanstvo u Eurotransplantu. U Älanku je opisana organizacija, povijest i uloga Eurotransplanta u alokaciji i razmjeni organa te mjesto Hrvatske u Eurotransplantu.Eurotransplant is an international non-profit organization that was founded in 1967. Its primary acitvities include allocation and cross-border exchange of organs for transplantation. Eurotransplant has eight member states and the Republic of Croatia joined in 2007. Some of the key advantages of membership in Eurotransplantās pool of potential organ donors include better matching between donors and recipients as well as the possibility to find an organ quickly for patients with acute organ failure. After joining Eurotransplant Croatia has experienced a tremendous rise in the number of cadaveric organ donors and solid organ transplants. Today, Croatia is one of the worldās leaders in cadaveric organ donation and organ transplantation and Croatian membership in Eurotransplant has been one of the key factors. This review gives an outline of the structure and history of Eurotransplant and explains its role in allocation and cross-border exchange of organs. The history of relations between Croatia and Eurotransplant is described as well
Dual Kidney Transplantation: Case Report
Chronic shortage of kidney transplants worldwide has led to the use of organs from so called marginal or borderline donors, now termed Ā»expanded-criteria donorsĀ«. There has been an emerging practice of dual kidney transplantation (DKT) to compensate for sub optimal nephron mass of such kidneys. We performed DKT in Ā»MerkurĀ« University Hospital in August 2005. The donor was a 72-year old female with a history of long-term hypertension, aneurysm of the posterior cerebral artery, cerebrovascular insult (CVI), and with normal creatinine values and kidney function at the time of explantation. Initial biopsy of donor kidneys revealed acute tubular damage, with connective changes in 22% and 11% of glomeruli in the left and the right kidney, respectively.The recipient was a 60-year old male diagnosed with the IgA nephropathy on the last biopsy in 1999, and on dialysis since November 2003. Postoperative course was uneventful without any surgical complications. A triple immunosuppressive protocol was used. On follow-up ultrasonography 4 years posttransplantation both kidneys appeared of normal size and parenchymal pattern and with no signs of dilatation of the canal system, and color Doppler examination demonstrated normal flow in both kidneys. In conclusion, the use of DKT, ie. donors by the expanded-criteria will continue to increase, and further studies of the results will, with no doubt, support this method
Successful management of unsuspected retroperitoneal paraganglioma via the use of combined epidural and general anesthesia: a case report
INTRODUCTION: Similar to pheochromocytomas, paragangliomas can secrete catecholamines, although they are usually non-functional and clinical presentation is non-specific. We present a case of accidental, intra-operatively diagnosed neuroendocrine-active sympathetic paraganglioma, which was suspected and confirmed during elective retroperitoneal tumor removal. CASE PRESENTATION: A 25-year-old Caucasian Croatian man, American Society of Anesthesiologists status 1, underwent elective surgery for retroperitoneal tumor removal. The tumor had been discovered by chance during a routine examination and was suspected to be a sarcoma. Our patient had no history of previous medical conditions nor did he have symptoms characteristic of a neuroendocrine secreting tumor. The results of ultrasound and magnetic resonance imaging studies showed a large, well demarcated retroperitoneal tumor mass in his upper abdomen localized between the aorta and vena cava, measuring approximately 9Ć6Ć4.5cm. In the operating room an epidural catheter was inserted at the T7 to T8 level prior to induction of general anesthesia. Epidural analgesia was maintained by an infusion pump with local anesthetic and opiate mixture. During the surgical excision of the tumor, hemodynamic changes occurred, with hypertension (205/110mmHg) and tachycardia (up to 120 beats/minute). In spite of the fact that the surgical field of work did not include adrenal glands whose direct manipulation could explain this occurrence, there was a high degree of suspicion for the presence of a neurosecreting tumor. His clinical symptoms were relieved after administration of urapidil, esmolol and magnesium sulfate. After tumor excision, our patient developed severe hypotension. Hemodynamic stability was reinstated with aggressive volume replacement, with crystalloids and colloids, vasopressors and hydrocortisone. His post-operative course was unremarkable and on the eighth post-operative day our patient was discharged from hospital, with no consequences or symptoms on follow-up two years after surgery. CONCLUSIONS: Our patientās case emphasizes the need to consider the presence of extra-adrenal paragangliomas in the differential diagnosis of retroperitoneal tumors, despite their rare occurrence. In our patientās case, invasive hemodynamic monitoring during combined general anesthesia and epidural analgesia and early recognition of catechol-induced symptoms raised suspicion of the existence of a paraganglioma, and this led to an adequate therapeutic approach and favorable outcome of the surgery. Pre-operative recognition of paragangliomas could lead to better pre-operative preparation, but even high clinical suspicion in undiagnosed forms during surgery and the availability of rapid and short-acting vasodilatators, Ī±-blockers and Ī²-blockers might favor good outcome
Fine Needle Aspiration Cytology of Adrenocortical Carcinoma ā Case Report
A 49-year-old woman presented for hirsutism, deep voice and hypertension. Ultrasonography (US) revealed a solitary tumor mass, eight cm in size, of the right adrenal gland. Laboratory tests showed it to be a hormonally active, androgen secreting tumor (elevated testosterone level), which was consistent with the clinical picture of the disease. After histopathological analysis tumor was signed out as adrenocortical carcinoma, a low risk carcinoma according to Weissā classification. One year later on regular follow up, US revealed a suspicious growth measuring 65x43 mm in the projection of the lower pole of the right kidney. The finding was verified by computerized tomography and the patient was reoperated on. Exploration revealed secondary growth in the region of greater omentum, without infiltration of adjacent organs. Histopathologic analysis confirmed metastatic ACC. 8 months after the second operation and after 6 chemotherapy cycles according to EAP protocol, control CT showed enlarged para-aortic lymph nodes and a node along the upper pole of the right kidney. Cytologic puncture was performed. Cytologic opinion was recidive of primary malignant disease. ACC is a rare malignant epithelial tumor of adrenal cortical cells, with high malignant potential. Morphologically (histopathology and cytology), differential diagnosis includes adenoma on the one hand, and renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC) on the other hand. A combined evaluation of clinical features, size or weight, microscopic appearance, immunohistochemical and molecular genetic data is necessary to ensure a correct diagnosis. The purpose of this case report is to present clinical and cytomorphologic features of our case of adrenocortical carcinoma which is very rare in cytology practice
Fine Needle Aspiration Cytology of Adrenocortical Carcinoma ā Case Report
A 49-year-old woman presented for hirsutism, deep voice and hypertension. Ultrasonography (US) revealed a solitary tumor mass, eight cm in size, of the right adrenal gland. Laboratory tests showed it to be a hormonally active, androgen secreting tumor (elevated testosterone level), which was consistent with the clinical picture of the disease. After histopathological analysis tumor was signed out as adrenocortical carcinoma, a low risk carcinoma according to Weissā classification. One year later on regular follow up, US revealed a suspicious growth measuring 65x43 mm in the projection of the lower pole of the right kidney. The finding was verified by computerized tomography and the patient was reoperated on. Exploration revealed secondary growth in the region of greater omentum, without infiltration of adjacent organs. Histopathologic analysis confirmed metastatic ACC. 8 months after the second operation and after 6 chemotherapy cycles according to EAP protocol, control CT showed enlarged para-aortic lymph nodes and a node along the upper pole of the right kidney. Cytologic puncture was performed. Cytologic opinion was recidive of primary malignant disease. ACC is a rare malignant epithelial tumor of adrenal cortical cells, with high malignant potential. Morphologically (histopathology and cytology), differential diagnosis includes adenoma on the one hand, and renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC) on the other hand. A combined evaluation of clinical features, size or weight, microscopic appearance, immunohistochemical and molecular genetic data is necessary to ensure a correct diagnosis. The purpose of this case report is to present clinical and cytomorphologic features of our case of adrenocortical carcinoma which is very rare in cytology practice
Parvovirus B 19 (PVB19) induced pure red cell aplasia (PRCA) in immunocompromised patient after liver transplantation [Izolirana aplazija crvene krvne loze uzrokovana infekcijom Parvovirusom B 19 nakon transplantacije jetre]
Presented here is a case of human parvovirus B19 (PVB19) induced pure red-cell aplasia (PRCA) in immunocompromised patient after orthotopic liver transplantation (OLT). PVB19 is a small, single-stranded DNA whose target cell is the erythroid progenitor in bone marrow. Manifestations of PVB19 infection vary with the immunologic status of the patient, ranging from asymptomatic to severe infections and PRCA. Post-transplant PRCA is induced either by immunosuppressive agents or PVB19. In the presented case, bone marrow aspiration characterized by the absence of mature erythroid precursors and detection of PVB19 DNA in blood led to treatment with high-dose intravenous human immunoglobulins (IVIG) and subsequent recovery of erythropoiesis. Due to insufficient antibody response in immunocompromised patients, suppression of the PVB19 infection is delayed and repetitive treatments may be administrated in attempt of reversing PRCA
Parvovirus B 19 (PVB19) Induced Pure Red Cell Aplasia (PRCA) in Immunocompromised Patient after Liver Transplantation
Presented here is a case of human parvovirus B19 (PVB19) induced pure red-cell aplasia (PRCA) in immunocompromised patient after orthotopic liver transplantation (OLT). PVB19 is a small, single-stranded DNA whose target cell is the erythroid progenitor in bone marrow. Manifestations of PVB19 infection vary with the immunologic status of the patient, ranging from asymptomatic to severe infections and PRCA. Post-transplant PRCA is induced either by immunosuppressive agents or PVB19. In the presented case, bone marrow aspiration characterized by the absence of mature erythroid precursors and detection of PVB19 DNA in blood led to treatment with high-dose intravenous human immunoglobulins (IVIG) and subsequent recovery of erythropoiesis. Due to insufficient antibody response in immunocompromised patients, suppression of the PVB19 infection is delayed and repetitive treatments may be administrated in attempt of reversing PRCA
Epitheloid Hemangioendothelioma in Patient with Liver Transplantation
Malignant hepatic epithelioid hemangioendothelioma (HEH) is a rare malignant tumor of vascular origin with unknown aetiology and a variable natural course. At the time of diagnosis, most patients present with multifocal tumours lesions that involve both liver lobes. From the therapeutic aspect, liver resection (LRx), liver transplantation (LTx), chemotherapy, radiotherapy, and/or immunotherapy have been used in the treatment of patients with HEH. However, because of the rarity of this tumor and its unpredictable natural history, it is impossible to assess the effectiveness of these respective therapies. In this report, our objective was to present clinical aspects, diagnostic options, therapeutic modalities, and the clinical outcome of single patient with LTx because of this rare tumor
Orthotopic Liver Retransplantation ā Case Report
We report a case of orthotopic liver retransplantation (OLRT) in a patient who was
suffering from rejection and graft failure after orthotopic liver transplantation (OLT).
The patient was a 32-year old female who had diagnosed liver lesion ā hepatic cirrhosis.
Within two months, with presented condition as a terminal stage of her disease, she underwent
the OLT and immunosuppressive postoperative management. Two months after
the OLT, in the one-week period, the patient underwent two new operations because
of obstructive icterus due to fulminant cholangitis and subhepatic abscess. In spite of
this operative and conservative treatment the patientās condition did not improve. Because
of graft failure due to bile duct necrosis, she underwent an ORLT operation and
her condition is satisfactory, till now. We confirmed that the overall impact of retransplatation
persists because patients undergoing elective retransplatation have significantly
better prognosis than those requiring an emergency operation